Mechanism of KDM4A in Regulating Microglial Polarization in Ischemic Stroke

Jingliang Du1, Xianyang Liang1, Denghui Wang1

  • 1Department of Neurology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, No. 24, Jinghua Road, Jianxi District, Luoyang, 471003, Henan Province, China.

Insights

Lysine-specific histone demethylase 4 (KDM4A) promotes harmful microglia polarization after ischemic stroke by regulating the MDM2/CTRP3 pathway, worsening brain injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Microglia polarization is critical in ischemic stroke inflammation.
  • Understanding the molecular mechanisms driving microglia polarization is essential for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of lysine-specific histone demethylase 4A (KDM4A) in microglia polarization following ischemic stroke.
  • To elucidate the underlying molecular mechanism involving mouse double minute-2 homolog (MDM2) and C1q/TNF-related protein-3 (CTRP3).

Main Methods:

  • Established mouse (MCAO/R) and cell (OGD/R) models of ischemic stroke.
  • Assessed neurological deficits, brain injury, microglia activation, and polarization markers.
  • Quantified KDM4A, MDM2, CTRP3 levels, inflammatory cytokines, and histone modifications (H3K9me3).
  • Investigated KDM4A's effect on MDM2 promoter enrichment and CTRP3 ubiquitination/degradation.

Main Results:

  • KDM4A and MDM2 were upregulated, while CTRP3 was downregulated post-stroke.
  • KDM4A inhibition improved neurological function, reduced inflammation, and promoted beneficial M2 microglia polarization.
  • KDM4A suppressed H3K9me3 on the MDM2 promoter, increasing MDM2 and decreasing CTRP3 via degradation.
  • MDM2 overexpression or CTRP3 knockdown mimicked KDM4A's pro-inflammatory effects.

Conclusions:

  • KDM4A drives pro-inflammatory microglia polarization in ischemic stroke.
  • The KDM4A/MDM2/CTRP3 axis represents a novel therapeutic target for mitigating ischemic stroke damage.